We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Two Trials Later, Boehringer Abandons ‘Female Viagra’
Two Trials Later, Boehringer Abandons ‘Female Viagra’
October 13, 2010
Boehringer Ingelheim is abandoning development of its so-called “female Viagra” to treat hypoactive sexual desire disorder (HSDD) in premenopausal women following a complete response letter and negative advisory panel vote.